The Advanced Therapy Medicinal Products Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Advanced Therapy Medicinal Products Market?
The market size of advanced therapy medicinal products has experienced swift growth recently. The market, valued at $42.85 billion in 2024, is projected to reach $51.34 billion in 2025, expanding at a compound annual growth rate (CAGR) of 19.8%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Advanced Therapy Medicinal Products Industry?
The Advanced Therapy Medicinal Products Global Market is projected to reach a size of $104.43 billion in 2029, with a compound annual growth rate (CAGR) of 19.4%.
Download Your Free Sample of the 2025 Advanced Therapy Medicinal Products Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Advanced Therapy Medicinal Products Market?
The key drivers in the advanced therapy medicinal products market are:
• Increasing demand for personalized medicine
• Growth in the use of advanced therapy medicinal products for tailored treatments
• Surging prevalence of chronic diseases, necessitating individualized treatment strategies
• Higher approval rate of personalized treatments by regulatory bodies such as the FDA
Global Market Segmentation: Identifying Major Advanced Therapy Medicinal Products Industry Segments
The advanced therapy medicinal products market covered in this report is segmented –
1) By Product: Somatic Cell Therapy Medicinal Products, Tissue Engineered Medicinal Products, Gene Therapy Medicinal Products
2) By Technology: Gene Editing Technologies, Viral Vector Technology, Stem Cell Technology, Automation And Artificial Intelligence-Driven Processes
3) By Application: Muscular Dystrophies, Alzheimer’s, Hemophilia, Cystic Fibrosis, Other Applications
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End User: Hospitals, Specialty Clinics, Other End Users
Pre-order the 2025 Advanced Therapy Medicinal Products Global Market Report for Fast Delivery & Comprehensive Insights!
What are the Emerging Trends Shaping the Future of the Advanced Therapy Medicinal Products Market?
The key trends in the advanced therapy medicinal products market are:
• Innovative therapies such as CAR-T cell therapies are an emerging trend.
• There is a focus on improving outcomes for severe diseases, including cancer.
• Genetically engineering patient's cells to recognize and destroy cancer cells is a developing technique.
• The rise of single-infusion treatments with sustained effects is shaping the future of the market.
Who Are the Top Competitors & Leading Players in the Advanced Therapy Medicinal Products Market?
Major players in the advanced therapy medicinal products market are:
• F. Hoffmann-La Roche Limited
• Novartis AG
• Bristol-Myers Squibb Company
• Takeda Pharmaceutical Company Limited
• Lonza Group AG
• Catalent Inc
• BioMarin Pharmaceutical Inc
• AGC Biologics Inc
• ViaCyte Inc
• Rentschler Biopharma SE
• JCR Pharmaceuticals Co. Ltd
• Vericel Corporation
• UniQure N.V.
• Fate Therapeutics Inc
• WuXi Advanced Therapies Inc
• Celonic Group AG
• Pharmicell Co. Ltd
• Magenta Therapeutics Inc
• MEDIPOST Co. Ltd
• Kolon TissueGene Inc
Regional Dominance: Which Area Leads the Global Advanced Therapy Medicinal Products Market?
North America was the largest region in the advanced therapy medicinal products market in 2024
